Vaccine treatment and evaluation units (VTEU) protocol development and implementation task area B-C phase II vaccine trial for influenza task order

Ended Awarded Last action

Contract number
HHSN27200009
Awardee
Awarding agency
Obligated
$2,623,644

Award facts

Opportunity
Contract value 54% obligated
  • $2,623,644.15 Current, with exercised options
  • $4,819,759.15 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Seattle, WA 98101, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00006 · The purpose of this modification is to DE-obligate remaining FY19 funds from line 2 of the task order. -$60,506
Supplemental Agreement for work within scope P00005 · The purpose of this modification is to deobligate FY17 funds, obligate cost to complete funds and extend the period of performance end date to 04/30/2023. $3,378
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · The purpose of this modification is to extend the period of performance end date from 12/31/20 to 06/30/21. $0
Supplemental Agreement for work within scope P00001 $140,476
Original award $2,540,296

About this award

Written by GovTribe AI ·

This federal contract award is for the VACCINE TREATMENT AND EVALUATION UNITS (VTEU) PROTOCOL DEVELOPMENT AND IMPLEMENTATION TASK AREA B-C PHASE II VACCINE TRIAL FOR INFLUENZA TASK ORDER, with a ceiling value of $4,819,759.15. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Kaiser Foundation Health Plan Of Washington. This is a delivery order issued under the Vaccine and Treatment Evaluation Units (VTEU) IDIQ contract, which supports vaccine research and development. The contract does not have a set-aside designation. Kaiser Foundation Health Plan Of Washington is a non-profit healthcare provider that has experience supporting federal agencies like the CDC, VA, and NIH on vaccine-related research and services.

Quick answers

Who was awarded contract HHSN27200009?

HHSN27200009 was awarded to Kaiser Foundation Health Plan Of Washington by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 27, 2017.

How much is contract HHSN27200009 worth?

The government has obligated $2,623,644 on HHSN27200009. Its potential value, with all options, is $4,819,759.

Is contract HHSN27200009 an order under another contract?

Yes. HHSN27200009 is a delivery order under HHSN272201300019I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200009 competed?

The extent of competition for HHSN27200009 was full and open competition. The government received 9 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login